Your session is about to expire
← Back to Search
Device
CPAP Therapy for Spinal Cord Injury
N/A
Recruiting
Led By Julio C Furlan, MD, FRCPC
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to 6 months after recruitment
Awards & highlights
No Placebo-Only Group
Summary
This trial will test if using a CPAP machine can help adults with spinal cord injuries who have serious sleep breathing problems. The machine helps them breathe better by keeping their airways open while they sleep.
Who is the study for?
The OPTIMISE SCI trial is for English-speaking adults over 18 with recent (≤30 days old) spinal cord injuries from C2 to T12, either complete or incomplete. It's not for those with non-traumatic spinal diseases, other central nervous system conditions, chronic pre-injury pain, significant psychiatric disorders, neuromuscular diseases, substance misuse issues, epilepsy, vitamin B12 deficiency or known hypersomnia unrelated to sleep-related breathing disorders.
What is being tested?
This study tests CPAP therapy on adults with spinal cord injury and sleep-related breathing disorders. Participants are divided into three groups: one gets early CPAP treatment at 6 weeks post-injury; another starts CPAP at 22 weeks; the third group doesn't get treatment if their SRBDs are mild or absent.
What are the potential side effects?
CPAP therapy side effects can include discomfort or irritation where the mask touches the face, dry nose or throat, runny nose, sneezing and congestion. Some people might feel claustrophobic wearing the mask and experience trouble falling asleep.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from baseline to 6 months after recruitment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to 6 months after recruitment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in International Standards for Neurological Classification of SCI (ISNCSCI) motor subscore from baseline to 6 months after recruitment
Change in International from baseline to 6 months after recruitment Standards for Neurological Classification of SCI (ISNCSCI) sensory subscore
Change in Spinal Cord Independence Measure (SCIM) - version III - score from baseline to 6 months after recruitment
Secondary study objectives
Change in Depression, Anxiety & Stress Scales- 21 (DASS-21) score from baseline to 6 months after recruitment
Change in Fatigue Severity Scale (FSS) from baseline to 6 months after recruitment
Change in Medical Outcomes Study Sleep Scale (MOS-SS) from baseline to 6 months after recruitment
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Early-CPAP therapy groupExperimental Treatment1 Intervention
Individuals diagnosed with moderate-to-severe sleep-related breathing disorders (SRBDs) who will start CPAP therapy within the first 6 weeks after SCI.
Group II: Delayed-CPAP therapy groupActive Control1 Intervention
Individuals diagnosed with moderate-to-severe SRBDs who will start on CPAP therapy at the 5th month after SCI.
Group III: Non-CPAP therapy groupActive Control1 Intervention
Individuals who are diagnosed with no or mild SRBD.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Continuous positive airway pressure (CPAP) therapy
2010
N/A
~80
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Spinal Cord Injury (SCI) focus on managing respiratory complications due to impaired respiratory muscle function and reduced lung volumes. CPAP therapy, for instance, provides continuous positive airway pressure to keep airways open during sleep, preventing airway collapse and improving oxygenation.
This is crucial for SCI patients who often have weakened respiratory muscles and compromised ventilatory control. Other treatments like noninvasive positive pressure ventilation (NPPV) and mechanical insufflation-exsufflation help maintain adequate ventilation and clear secretions, reducing the risk of pneumonia and other pulmonary issues.
These interventions are essential for enhancing respiratory function and overall quality of life in SCI patients.
Effects of Respiratory Muscle Training on Baroreflex Sensitivity, Respiratory Function, and Serum Oxidative Stress in Acute Cervical Spinal Cord Injury.Impact of cervical spinal cord contusion on the breathing pattern across the sleep-wake cycle in the rat.The immediate effects of breathing with oscillated inspiratory and expiratory airflows on secretion clearance in intubated patients with cervical spinal cord injury.
Effects of Respiratory Muscle Training on Baroreflex Sensitivity, Respiratory Function, and Serum Oxidative Stress in Acute Cervical Spinal Cord Injury.Impact of cervical spinal cord contusion on the breathing pattern across the sleep-wake cycle in the rat.The immediate effects of breathing with oscillated inspiratory and expiratory airflows on secretion clearance in intubated patients with cervical spinal cord injury.
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,531 Previous Clinical Trials
504,256 Total Patients Enrolled
Sunnybrook Health Sciences CentreOTHER
681 Previous Clinical Trials
1,565,692 Total Patients Enrolled
Julio C Furlan, MD, FRCPCPrincipal InvestigatorKITE Research Institute, University Health Network
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have epilepsy.I am 18 or older and speak English.I have a spinal cord condition like MS that could get worse.I have a pre-existing brain or nerve condition.I have a diagnosed sleep disorder not caused by sleep-related breathing problems.I wasn't treated for sleep apnea before my spinal cord issue began.My spinal cord injury is recent and located between my neck and mid-back.I have a neuromuscular disease.I have a brain or spinal cord disease.
Research Study Groups:
This trial has the following groups:- Group 1: Early-CPAP therapy group
- Group 2: Delayed-CPAP therapy group
- Group 3: Non-CPAP therapy group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.